Cargando…

Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM

OBJECTIVES: Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete’s heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gastl, Mareike, Lachmann, Vera, Christidi, Aikaterini, Janzarik, Nico, Veulemans, Verena, Haberkorn, Sebastian, Holzbach, Leonie, Jacoby, Christoph, Schnackenburg, Bernhard, Berrisch-Rahmel, Susanne, Zeus, Tobias, Kelm, Malte, Bönner, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043946/
https://www.ncbi.nlm.nih.gov/pubmed/33063183
http://dx.doi.org/10.1007/s00330-020-07289-4
_version_ 1783678400892764160
author Gastl, Mareike
Lachmann, Vera
Christidi, Aikaterini
Janzarik, Nico
Veulemans, Verena
Haberkorn, Sebastian
Holzbach, Leonie
Jacoby, Christoph
Schnackenburg, Bernhard
Berrisch-Rahmel, Susanne
Zeus, Tobias
Kelm, Malte
Bönner, Florian
author_facet Gastl, Mareike
Lachmann, Vera
Christidi, Aikaterini
Janzarik, Nico
Veulemans, Verena
Haberkorn, Sebastian
Holzbach, Leonie
Jacoby, Christoph
Schnackenburg, Bernhard
Berrisch-Rahmel, Susanne
Zeus, Tobias
Kelm, Malte
Bönner, Florian
author_sort Gastl, Mareike
collection PubMed
description OBJECTIVES: Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete’s heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by cardiovascular magnetic resonance (CMR) to discriminate AH from HCM with (HOCM) or without outflow tract obstruction (HNCM). METHODS: Thirty-three patients with HOCM, 9 with HNCM, 13 strength-trained athletes as well as individual age- and gender-matched controls received CMR. For T2 mapping, GRASE-derived multi-echo images were obtained and analyzed using dedicated software. Besides T2 mapping analyses, left ventricular (LV) dimensional and functional parameters were obtained including LV mass per body surface area (LVMi), interventricular septum thickness (IVS), and global longitudinal strain (GLS). RESULTS: While LVMi was not significantly different, IVS was thickened in HOCM patients compared to athlete’s. Absolute values of GLS were significantly increased in patients with HOCM/HNCM compared to AH. Median T2 values were elevated compared to controls except in athlete’s heart. ROC analysis revealed T2 values (AUC 0.78) and GLS (AUC 0.91) as good parameters to discriminate AH from overall HNCM/HOCM. CONCLUSION: Discrimination of pathologic from non-pathologic LVH has implications for risk assessment of competitive sports in athletes. Multiparametric CMR with parametric T2 mapping and deformation imaging may add information to distinguish AH from LVH due to HCM. KEY POINTS: • Structural analyses using T2 mapping cardiovascular magnetic resonance imaging (CMR) may help to further distinguish myocardial diseases. • To differentiate pathologic from non-pathologic left ventricular hypertrophy, CMR including T2 mapping was obtained in patients with hypertrophic obstructive/non-obstructive cardiomyopathy (HOCM/HNCM) as well as in strength-trained athletes. • Elevated median T2 values in HOCM/HNCM compared with athlete’s may add information to distinguish athlete’s heart from pathologic left ventricular hypertrophy.
format Online
Article
Text
id pubmed-8043946
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-80439462021-04-27 Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM Gastl, Mareike Lachmann, Vera Christidi, Aikaterini Janzarik, Nico Veulemans, Verena Haberkorn, Sebastian Holzbach, Leonie Jacoby, Christoph Schnackenburg, Bernhard Berrisch-Rahmel, Susanne Zeus, Tobias Kelm, Malte Bönner, Florian Eur Radiol Cardiac OBJECTIVES: Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete’s heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by cardiovascular magnetic resonance (CMR) to discriminate AH from HCM with (HOCM) or without outflow tract obstruction (HNCM). METHODS: Thirty-three patients with HOCM, 9 with HNCM, 13 strength-trained athletes as well as individual age- and gender-matched controls received CMR. For T2 mapping, GRASE-derived multi-echo images were obtained and analyzed using dedicated software. Besides T2 mapping analyses, left ventricular (LV) dimensional and functional parameters were obtained including LV mass per body surface area (LVMi), interventricular septum thickness (IVS), and global longitudinal strain (GLS). RESULTS: While LVMi was not significantly different, IVS was thickened in HOCM patients compared to athlete’s. Absolute values of GLS were significantly increased in patients with HOCM/HNCM compared to AH. Median T2 values were elevated compared to controls except in athlete’s heart. ROC analysis revealed T2 values (AUC 0.78) and GLS (AUC 0.91) as good parameters to discriminate AH from overall HNCM/HOCM. CONCLUSION: Discrimination of pathologic from non-pathologic LVH has implications for risk assessment of competitive sports in athletes. Multiparametric CMR with parametric T2 mapping and deformation imaging may add information to distinguish AH from LVH due to HCM. KEY POINTS: • Structural analyses using T2 mapping cardiovascular magnetic resonance imaging (CMR) may help to further distinguish myocardial diseases. • To differentiate pathologic from non-pathologic left ventricular hypertrophy, CMR including T2 mapping was obtained in patients with hypertrophic obstructive/non-obstructive cardiomyopathy (HOCM/HNCM) as well as in strength-trained athletes. • Elevated median T2 values in HOCM/HNCM compared with athlete’s may add information to distinguish athlete’s heart from pathologic left ventricular hypertrophy. Springer Berlin Heidelberg 2020-10-15 2021 /pmc/articles/PMC8043946/ /pubmed/33063183 http://dx.doi.org/10.1007/s00330-020-07289-4 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Cardiac
Gastl, Mareike
Lachmann, Vera
Christidi, Aikaterini
Janzarik, Nico
Veulemans, Verena
Haberkorn, Sebastian
Holzbach, Leonie
Jacoby, Christoph
Schnackenburg, Bernhard
Berrisch-Rahmel, Susanne
Zeus, Tobias
Kelm, Malte
Bönner, Florian
Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM
title Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM
title_full Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM
title_fullStr Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM
title_full_unstemmed Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM
title_short Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM
title_sort cardiac magnetic resonance t2 mapping and feature tracking in athlete’s heart and hcm
topic Cardiac
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043946/
https://www.ncbi.nlm.nih.gov/pubmed/33063183
http://dx.doi.org/10.1007/s00330-020-07289-4
work_keys_str_mv AT gastlmareike cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT lachmannvera cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT christidiaikaterini cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT janzariknico cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT veulemansverena cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT haberkornsebastian cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT holzbachleonie cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT jacobychristoph cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT schnackenburgbernhard cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT berrischrahmelsusanne cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT zeustobias cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT kelmmalte cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm
AT bonnerflorian cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm